Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Association of the long fluoroscopy time with factors in contemporary primary percutaneous coronary interventions.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- معلومة اضافية
- المصدر:
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
- بيانات النشر:
Original Publication: San Francisco, CA : Public Library of Science
- الموضوع:
- نبذة مختصرة :
Background: Since the long fluoroscopy time in primary PCI for ST-segment elevation myocardial infarction (STEMI) could be an indicator of delayed reperfusion, it should be important to recognize which types of lesions require longer fluoroscopy-time in primary PCI. The purpose of this study was to investigate the association of the long fluoroscopy-time with clinical factors in primary percutaneous coronary interventions (PCI).
Methods: A total of 539 patients who underwent primary PCI were divided into the conventional fluoroscopy-time group (Q1-Q4: n = 434) and the long fluoroscopy-time group (Q5: n = 105) according to the quintile of the total fluoroscopy time in primary PCI. Univariate and multivariate logistic regression analyses were performed to find associations between clinical variables and the long fluoroscopy-time.
Results: In univariate logistic regression analysis, prevalence of diabetes mellitus, hemodialysis, and previous CABG were significantly associated with the long fluoroscopy-time. In addition, complex lesion characteristics such as lesion length, lesion angle, tortuosity, and calcification were associated with the long fluoroscopy-time. In multivariable logistic regression analysis, lesion length [per 10 mm incremental: odds ratio (OR) 1.751, 95% confidence interval (CI) 1.397-2.195, P<0.001], moderate-excessive tortuosity (vs. mild tortuosity: OR 4.006, 95% CI 1.498-10.715, P = 0.006), and moderate to severe calcification (vs. none-mild calcification: OR 1.865, 95% CI 1.107-3.140, P = 0.019) were significantly associated with the long fluoroscopy-time.
Conclusions: In primary PCI for STEMI, diffuse long lesion, tortuosity, and moderate-severe calcification were associated with the long fluoroscopy-time. These complex features require special attention to reduce reperfusion time in primary PCI.
Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Sakakura has received speaking honoraria from Abbott Vascular, Boston Scientific, Medtronic Cardiovascular, Terumo, OrbusNeich, Japan Lifeline, and NIPRO; he has served as a proctor for Rotablator for Boston Scientific; and he has served as a consultant for Abbott Vascular and Boston Scientific. Prof. Fujita has served as a consultant for Mehergen Group Holdings, Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
- References:
Circulation. 1990 Oct;82(4):1193-202. (PMID: 2401060)
Cardiovasc Revasc Med. 2018 Jul - Aug;19(5 Pt B):607-612. (PMID: 29358042)
Lancet. 2003 Jan 4;361(9351):13-20. (PMID: 12517460)
Am J Cardiol. 2014 Apr 1;113(7):1087-92. (PMID: 24513475)
N Engl J Med. 2016 Dec 15;375(24):2349-2358. (PMID: 27959714)
Am J Nephrol. 1988;8(4):261-71. (PMID: 3055991)
N Engl J Med. 1999 Aug 26;341(9):625-34. (PMID: 10460813)
J Invasive Cardiol. 2012 Dec;24(12):650-4. (PMID: 23220980)
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140. (PMID: 23256914)
Coron Artery Dis. 2014 Mar;25(2):145-51. (PMID: 24281252)
Int Heart J. 2018 Nov 28;59(6):1237-1245. (PMID: 30305588)
Crit Care Med. 2019 Nov;47(11):1564-1571. (PMID: 31393321)
J Invasive Cardiol. 2007 May;19(5):208-13. (PMID: 17476034)
JACC Cardiovasc Interv. 2019 Nov 25;12(22):2260-2268. (PMID: 31678083)
Circ J. 2014;78(9):2209-14. (PMID: 25017740)
Curr Cardiol Rev. 2020;16(2):117-124. (PMID: 31648644)
Angiology. 1986 Nov;37(11):828-31. (PMID: 2947525)
Catheter Cardiovasc Interv. 2003 Jul;59(3):324-8. (PMID: 12822150)
Eur J Clin Invest. 2020 Feb;50(2):e13197. (PMID: 31883102)
Circulation. 2008 Dec 16;118(25):2694-701. (PMID: 19106392)
JACC Cardiovasc Interv. 2017 Nov 13;10(21):2144-2154. (PMID: 29055764)
Am J Cardiol. 2004 Jul 1;94(1):108-11. (PMID: 15219518)
Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S8-14. (PMID: 25945803)
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. (PMID: 30153967)
Eur Heart J. 2007 Jul;28(14):1709-16. (PMID: 17556348)
Pak J Med Sci. 2019 Jan-Feb;35(1):166-171. (PMID: 30881417)
Circulation. 1995 Apr 1;91(7):1959-65. (PMID: 7895353)
Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1091-105. (PMID: 23703793)
J Am Coll Cardiol. 1999 Mar 15;33(4):1005-12. (PMID: 10091828)
Am J Kidney Dis. 2009 Jun;53(6):982-92. (PMID: 19339088)
J Am Coll Cardiol. 2000 Sep;36(3):959-69. (PMID: 10987628)
Circulation. 1988 Aug;78(2):486-502. (PMID: 2969312)
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):370-6. (PMID: 21805596)
- الموضوع:
Date Created: 20200811 Date Completed: 20201013 Latest Revision: 20201013
- الموضوع:
20240628
- الرقم المعرف:
PMC7416924
- الرقم المعرف:
10.1371/journal.pone.0237362
- الرقم المعرف:
32776989
No Comments.